Plerixafor is a stem cell mobilising agent, and when administered along with G-CSF has been shown to improve CD34+ stem cell collections in lymphoma and multipl
<div style="text-align:justify;"> Circulating extracellular RNAs (exRNAs) are very important potential biomarkers of disease. But few have been reported the ext